Where does ReShape Medical LLC rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), ReShape Medical LLC ranks #20,317 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does ReShape Medical LLC hold?

ReShape Medical LLC holds 14 US utility patents granted between 2015 and 2018, spanning 8 technology areas.

What is ReShape Medical LLC's Innovation Score?

ReShape Medical LLC has an Innovation Score of 27.8 out of 100 (25th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is ReShape Medical LLC's patent grant rate increasing or decreasing?

ReShape Medical LLC's recent grant velocity is -100% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for ReShape Medical LLC's patents?

ReShape Medical LLC's patents average 14.1 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the ReShape Medical LLC patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

ReShape Medical LLC

Q: What technology areas does ReShape Medical LLC focus on?

ReShape Medical LLC's top technology area is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs) with 14 patents, ranking #463 of 3,082 assignees active in that subclass. Grants appear in 8 CPC subclasses total.

USPTO PatentsView assignee record - 14 granted patents across 8 technology areas, recorded in grant years 2015–2018. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Reshape ranks #20,317 of 49,997 tracked US assignees by granted-patent volume, with 14 patents across 8 technology areas.

#20,317
of 49,997 US assignees by volume: 25th percentile
by Innovation Score (27.8/100): 14.1
avg claims per patent: -100%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R20317 · US Corporation #20,317 · 14 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DROP · BOOK-FULL

GRANTS-MICRO 14 grants
MID-PACK #20,317/49,997
PHOTO-FINISH Radius Health
CPC-NARROW A61F · 8 areas
INNOV-THIN 27.8/100
CLAIMS-RICH 14.1 claims/avg
TYPE-USCORP US Corporation
VEL-DROP -100% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Radius Health, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Reshape’s 27.8 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 9.4 pts (34%) Velocity 0.0 pts (0%) Breadth 10.0 pts (36%) Claim depth 8.5 pts (30%)

Qualcomm Incorporated · highest

85
ReShape Medical · this assignee

28
3D Lighting… · lowest

7

What this shows Reshape's Innovation Score is 27.8/100 (25th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Reshape?

Each dot is one of Reshape’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Reshape’s own 14.1 claims/patent is at or below the 16.7 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Reshape vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Reshape's grants concentrate

ReShape Medical LLC is a focused PatentsView assignee: 8 CPC subclasses with 100% of grants classified under A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device). Peak complete grant year is 2017 (6 grants) versus a trough of 2 in 2016. By volume, Reshape sits between Radius Health, Inc. and Regina Miracle International (Group) Limited.

Radius Health

14
Radix

14
Rado Watch

14
Raymond & Lae Eng…

14
Reavire

14
Rebate Assets

14
Redmed

14
Regina Miracle In…

14
Reshape Medical ◀

14

What this shows ReShape holds 14 patents at rank #20,323, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near ReShape

By rank, the assignees closest to #20,323 in granted patent volume.

Leaders in A61F (Filters Implantable Into Blood Vessels)

Other assignees with the most granted patents in ReShape's primary technology class.

Reshape's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

28 25th percentile higher than 25% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2018

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

ReShape Medical LLC patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	3	21.4%
2016	2	14.3%
2017	6	42.9%
2018	3	21.4%

Which technologies does ReShape Medical LLC patent most?

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 14

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 11

A61B - DIAGNOSIS; SURGERY; Identification 4

A61L - Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES; Materials FOR Bandages, Dressings, Absorbent Pads OR Surgical Articles 4

B29K - Indexing Scheme Associated With Subclasses B29b, B29c OR B29d, Relating TO Moulding Materials OR TO Materials FOR ; Moulds, ; Reinforcements, Fillers OR Preformed Parts, e.g. Inserts 2

B29D - Producing Particular Articles From Plastics OR From Substances IN A Plastic State 2

Y10T - Technical Subjects Covered BY Former US Classification 2

F04B - Positive-displacement Machines FOR LIQUIDS; Pumps 1

Top 8 of 8 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

ReShape Medical LLC's patent record in context - here's where to go next.

ReShape Medical LLC's lead technology class is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device), 100% of its portfolio - see every assignee active in that class. Explore A61F
Ranked #20,317 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare ReShape Medical LLC against Radius Health, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 27.8/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.